Key facts
- This page summarizes Robert Fischell's Form 4 filing for Glucotrack, Inc. (GCTK).
- 3 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 28 Mar 2025, 20:53.
Robert Fischell - 24 Aug 2021 Form 4 Insider Report for Glucotrack, Inc. (GCTK)
- Reporting relationship
- Director
- Issuer ticker
- GCTK
- Reported as of
- 24 Aug 2021
- Net transaction value
- $0
- Reporting owner signature
- /s/ Nelson Mullins Riley & Scarborough LLP, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Robert Fischell filed Form 4 for Glucotrack, Inc. (GCTK) on 28 Mar 2025.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
GCTK
transaction
Common Stock, par value $0.001 per share
Award
- Transaction value
- $0
- Shares
- +318
- Change %
- Price
- $0.000000
- Shares after
- 318
- Date
- 24 Aug 2021
- Ownership
- Direct
GCTK
transaction
Common Stock, par value $0.001 per share
Award
- Transaction value
- $0
- Shares
- +229
- Change %
- +72%
- Price
- $0.000000
- Shares after
- 547
- Date
- 08 Apr 2024
- Ownership
- Direct
GCTK
transaction
Common Stock, par value $0.001 per share
Award
- Transaction value
- $0
- Shares
- +1,498
- Change %
- +274%
- Price
- $0.000000
- Shares after
- 2,045
- Date
- 26 Mar 2025
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
SEC remarks
Exhibit List: Exhibit 24 - Power of Attorney Note: On May 17, 2024, a 1-for-5 reverse stock split of the Issuer's common stock, par value $0.001 per share (the "Common Stock") was implemented (the "2024 Reverse Split"). On February 25, 2025, a 1-for-20 reverse stock split of the Common Stock was implemented (the "2025 Reverse Split," and together with the 2024 Reverse Split, the "Reverse Stock Splits"). All figures presented in this Form 4 reflect the Reverse Stock Splits.